Singapore Biotech is a trusted Biologic company that changes lives by making advanced biologics more accessible and more affordable.
The EU-GMP certified manufacturing facilities enable us to deliver world-class quality biosimilars to patients, across the globe.
Utilizing latest manufacturing technologies is our competitive edge to support our international partners to increase uptake of biosimilars in different regions.

Business Model and Partnering Structures at Singapore Biotech:

·         Out licensing
·         Supply and Distribution (API and Finished Product)
·         Technology Transfer
·         Co-Development
·         Contract Manufacturing

Our Target Therapeutic Areas:

·         Neurology (Interferon beta-1a)
·         Oncology & Hematology (Erythropoietin beta, Pegylated filgrastim, Rituximab, Trastuzumab, Bevacizumab and rFactor VII)
·         Gynecology & Endocrinology (Follitropin alfa and Somatropin)
·         Rheumatology (Teriparatide, Adalimumab and Etanercept)


Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

CinnoRA

Singapore Biotech Pte. Ltd.

Request Info

CinnoPar

Singapore Biotech Pte. Ltd.

Request Info

AryoSeven

Singapore Biotech Pte. Ltd.

Request Info

Stivant

Singapore Biotech Pte. Ltd.

Request Info

Categories affiliated with Singapore Biotech Pte. Ltd.